Načítá se...
Late erythropoiesis‐stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants
BACKGROUND: Preterm infants have low plasma levels of erythropoietin (EPO), providing a rationale for the use of erythropoiesis‐stimulating agents (ESAs) to prevent or treat anaemia. Darbepoetin (Darbe) and EPO are currently available ESAs. OBJECTIVES: To assess the effectiveness and safety of late...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6986694/ https://ncbi.nlm.nih.gov/pubmed/31990982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004868.pub6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|